The Synergy of BPC-157 and TB-500
In regenerative medicine research, combining BPC-157 and TB-500 represents the most popular protocol for tissue repair. While each peptide is powerful individually, their co-administration triggers synergistic pathways that significantly accelerate recovery in bone, tendon, ligament, and muscle models.
BPC-157 acts as a powerful healing organizer, upregulating growth factors, promoting nitric oxide synthesis, and repairing cell-to-cell junctions. TB-500 complements this by promoting actin cell migration and blood vessel growth, providing the raw cellular mobility required to rebuild damaged tissues.
Why Choose a Co-Lyophilized Blend?
Historically, researchers had to purchase separate vials of BPC-157 and TB-500, calculate separate dilutions, and perform multiple injections. The Wolverine Blend simplifies this by freeze-drying both peptides in a single vial during synthesis.
This co-lyophilization process ensures a perfect 1:1 molecular distribution, reduces the risk of contamination during mixing, and halves the number of required injections, preserving research accuracy and budget.
Reconstitution & Syringe Math
A standard Wolverine Blend vial contains 10mg of total peptide weight (5mg BPC-157 + 5mg TB-500). To mix:
1. Slowly inject 2.0 ml of bacteriostatic water into the vial.
2. This yields a concentration of 5.0mg (5000mcg) of total peptide per ml (containing 2.5mg of BPC-157 and 2.5mg of TB-500).
A standard research dose of 500mcg of total peptide (containing 250mcg of BPC-157 and 250mcg of TB-500) corresponds to exactly 10 units on a U-100 syringe.